Genmab | GEN - Stock

Aktienkurs
1,711.00
Täglich Wechseln
-32.50 -1.86%
Monatlich
2.30%
Jährlich
27.02%
Q2 Prognose
1,628.53




Stock Veränderung Datum
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Almirall EUR 178.13M 1.54M 2025-12
Amarin USD 184.7M 13.46M 2025-09
Amgen USD 6.22B 121M 2025-12
argenx SE USD 340.62M 66.61M 2025-06
AstraZeneca USD 6.59B 126M 2025-09
Bayer EUR 12.33B 221M 2025-09
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Demant DKK 2.62B 78M 2025-12
Exelixis USD 27.4M 3.92M 2025-09
Fresenius Medical Care EUR 2.14B 54.28M 2025-12
Galapagos EUR 22.95M 15.57M 2025-09
Genmab DKK 13M 1000K 2025-06
GlaxoSmithKline GBP 6.12B 46M 2025-09
GN Store Nord DKK 2.38B 26M 2025-09
GRIFOLS EUR 3.35B 213.23M 2025-06
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Insmed USD 132.07M 11.1M 2025-12
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.51B 42M 2025-09
Novartis USD 6.42B 114M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
UCB EUR 1.31B 173M 2024-12